InsidersTradesSigma
Browse the full directors' dealings record of PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025, a listed issuer based in Italy. Shares trade on IT IT, under the oversight of Consob. All data is free.
0 of 0 declarations